HIKMA PHARMACEUTIC.LS-,10/ GB00B0LCW083 /
10/09/2024 14:39:44 | Chg. -0.600 | Volume | Bid14:39:44 | Ask14:39:44 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
22.600EUR | -2.59% | - Turnover: - |
22.600Bid Size: - | 23.000Ask Size: - | 5 bill.EUR | - | - |
Assets
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 969 | 828 | 870 | 912 | 1,009 | ||||||
Intangible Assets | 1,037 | 503 | 487 | 552 | 587 | ||||||
Long-Term Investments | 55 | 66 | 68 | 43 | 48 | ||||||
Fixed Assets | 2,915 | 1,814 | 1,829 | 2,082 | 2,213 | ||||||
Inventories | 459 | 488 | 528 | 568 | 757 | ||||||
Accounts Receivable | 759 | 707 | 731 | 719 | 756 | ||||||
Cash and Cash Equivalents | 155 | 227 | 276 | 442 | 323 | ||||||
Current Assets | 1,448 | 1,574 | 1,668 | 1,848 | 1,922 | ||||||
Total Assets | 4,363 | 3,388 | 3,497 | 3,930 | 4,135 |
Liabilities
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 343 | 365 | 465 | 473 | 470 | ||||||
Long-term debt | 721 | 670 | 539 | 48 | 692 | ||||||
Liabilities to Banks | 838 | 756 | 613 | 617 | 850 | ||||||
Provisions | 42 | 75 | 39 | 43 | 59 | ||||||
Liabilities | 1,952 | 1,860 | 1,800 | 1,801 | 1,987 | ||||||
Share Capital | 40 | 40 | 40 | 41 | 41 | ||||||
Total Equity | 2,396 | 1,514 | 1,685 | 2,117 | 2,135 | ||||||
Minority Interests | 15 | 14 | 12 | 12 | 13 | ||||||
Total liabilities equity | 4,363 | 3,388 | 3,497 | 3,930 | 4,135 |
Income Statement
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,950 | 1,936 | 2,070 | 2,207 | 2,341 | ||||||
Depreciation (total) | - | - | - | - | 2 | ||||||
Operating Result | 302 | -747 | 371 | 493 | 579 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | 210 | -738 | 293 | 491 | 558 | ||||||
Income Taxes | -52 | -101 | -8 | -4 | -128 | ||||||
Minority Interests Profit | -3 | -4 | -4 | -1 | 1 | ||||||
Net Income | 155 | -843 | 282 | 486 | 431 |
Per Share
Cash Flow
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 293 | 443 | 430 | 472 | 464 | ||||||
Cash Flow from Investing Activities | -695 | -151 | -96 | -151 | -283 | ||||||
Cash Flow from Financing | 19 | -220 | -278 | -155 | -298 | ||||||
Decrease / Increase in Cash | -383 | 72 | 56 | 166 | -117 | ||||||
Employees | 8,339 | 8,521 | 8,413 | 8,578 | 8,681 |